KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash from Operations (2016 - 2025)

Eli Lilly (LLY) has disclosed Cash from Operations for 17 consecutive years, with 3224600000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 30.34% year-over-year to 3224600000.0, compared with a TTM value of 16813000000.0 through Dec 2025, up 90.67%, and an annual FY2025 reading of 16813000000.0, up 90.67% over the prior year.
  • Cash from Operations was 3224600000.0 for Q4 2025 at Eli Lilly, down from 8835900000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8835900000.0 in Q3 2025 and bottomed at 312000000.0 in Q4 2023.
  • Average Cash from Operations over 5 years is 2241130000.0, with a median of 1753050000.0 recorded in 2021.
  • The sharpest move saw Cash from Operations crashed 118.76% in 2023, then soared 892.92% in 2024.
  • Year by year, Cash from Operations stood at 2261700000.0 in 2021, then decreased by 26.48% to 1662700000.0 in 2022, then crashed by 118.76% to 312000000.0 in 2023, then skyrocketed by 892.92% to 2473900000.0 in 2024, then surged by 30.34% to 3224600000.0 in 2025.
  • Business Quant data shows Cash from Operations for LLY at 3224600000.0 in Q4 2025, 8835900000.0 in Q3 2025, and 3086900000.0 in Q2 2025.